News
AstraZeneca CEO Pascal Soriot discusses earnings, the potential trade tariff impact on the business and the outlook for the ...
Canadian Prime Minister Mark Carney danced with supporters after results from Monday's (April 28) election saw a comeback ...
In his final article for Sky News, Ian reflects on the big stories and changes he has seen and reveals what depressed and surprised him the most while covering some of the century's biggest economic ...
At AstraZeneca, she was the global head of the ... In a LinkedIn post last week, Chaudhuri shared several photos to commemorate her “incredible journey at Johnson & Johnson” and to celebrate ...
In her final engagement the Secretary of State for Wales visited Ipsen Biopharm, a global biopharmaceutical company with a ...
Speaking a day before Donald Trump’s reciprocal tariffs are expected to be announced, Karoline Leavitt said: “Our country has been one of the most open economies in the world and we have the consumer ...
Follow our latest tariffs coverage in our live blog; Donald Trump has paused his tariff onslaught for 90 days in a major ...
The government is looking at "possible retaliatory action" after the US confirmed a 10% levy on goods imported from the UK.
World News // 9 hours ago Vatican releases photos of Pope Francis' tomb as it opens for viewing April 27 (UPI) -- The Vatican released photos of the tomb of Pope Francis as it was opened for ...
Co-founder and CEO Rebekka Mikkola says: “Being part of Founders is a huge privilege. Founders gives us a trusted community ...
AstraZeneca expects only limited impact from potential U.S. tariffs on pharmaceutical imports, the drugmaker said on Tuesday, ...
On a per-share basis, the Cambridge, Britain-based company said it had profit of 93 cents. Earnings, adjusted for non-recurring costs, came to $1.24 per share. The results topped Wall Street ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results